Roche picks up a speedy nod in China as regulators follow through on plans for a fast 48 new drug OKs
Chinese regulatory authorities are following through with their plan to rush along a slate of new drug approvals. And Roche finds itself near the front …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
